Sartorius | SRT3 - Fremdkapital

Aktienkurs
220.20
Täglich Wechseln
12.10 5.81%
Monatlich
2.61%
Jährlich
23.19%
Q2 Prognose
206.18




Fremdkapital Veränderung Datum
Akebia Therapeutics USD 48.25M 609K 2025-12
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Dianthus Therapeutics USD 0 0 2024-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
Moderna USD 610M 584M 2025-12
Organon & Co USD 8.78B 117M 2025-09
Revvity USD 2.63B 543K 2025-12
Sartorius EUR 3.41B 682.5M 2025-09
Tectonic Therapeutic USD 43K 57K 2025-12
Viatris USD 12.48B 7M 2025-12
Xeris Pharmaceuticals USD 220.33M 866K 2025-12